Review



recombinant human ccl5 protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress recombinant human ccl5 protein
    Recombinant Human Ccl5 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human ccl5 protein/product/MedChemExpress
    Average 93 stars, based on 4 article reviews
    recombinant human ccl5 protein - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress recombinant human ccl5 protein
    Recombinant Human Ccl5 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human ccl5 protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    recombinant human ccl5 protein - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems met ccl5
    Met Ccl5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/met ccl5/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    met ccl5 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    92
    Boster Bio ccl5
    Serum CCR1 ligand concentrations (pg/mg) at baseline (t = 0 min) and at the end of the experiment (t = 210 min). Light grey bars: vehicle treatment, n = 7. Dark grey bars: 0.5 μmol/kg BX471 treatment, n = 7. ( A ) CCL3, ( B ) CCL4, ( C ) <t>CCL5,</t> and ( D ) CCL7. *: p < 0.05 vs. baseline (t = 0 min).
    Ccl5, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl5/product/Boster Bio
    Average 92 stars, based on 1 article reviews
    ccl5 - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    92
    Boster Bio ccl11
    NOX4 enhanced the CD8 + T cells mediate antitumor effect. (A) TIMER2.0 was used to analysis the correlation between NOX4 expression levels and CD8 + T cell infiltration, Scatter plot showing the correlation between NOX4 expression levels and CD8 + T cell infiltration in breast cancer (BRCA) samples (n=1100). Rho=0.346, p=2.57e-26. (B) TISIDB data: Scatter plot showing the correlation between NOX4 expression and central memory CD8 + T cell (Tcm-CD8) infiltration, effector memory CD8+ T cell (Tem-CD8) in BRCA samples (n=1100). Rho=0.44, p<2.2e-16; Rho=0.171, p<1.24e-6. (C) Representative flow cytometry plots showing the percentage of CD8 + T cells within the CD45 + population in EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of CD8 + cells, showing a significant reduction in CD8 + T cell infiltration in NOX4 KO tumors ***p<0.001. n=6 per group. (D) Representative flow cytometry plots showing IFN-γ and Granzyme B expression in CD8 + T cells from EO771 tumors of NOX4 WT and NOX4 KO mice. Bar graphs quantifying the percentage of CD8 + T cells expressing IFN-γ and Granzyme B, ***p<0.001. n=7 per group. (E) Representative flow cytometry plots showing the percentage of DC cells within the EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of DC cells, **p<0.01. n=7 per group. (F) TISIDB data: Scatter plot showing the correlation between NOX4 expression and <t>CCL11</t> expression in BRCA samples (n=1100). A significant positive correlation is observed. Rho=0.359, p<2.2e-16. Bar graph showing the concentration of CCL11, CCL5 in the tumor microenvironment, *p<0.05. Data are presented as mean ± SEM from 3 independent experiments. Statistical significance was determined using two-tailed Student’s t-test.
    Ccl11, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl11/product/Boster Bio
    Average 92 stars, based on 1 article reviews
    ccl11 - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    90
    Abnova recombinant human ccl5 protein
    NOX4 enhanced the CD8 + T cells mediate antitumor effect. (A) TIMER2.0 was used to analysis the correlation between NOX4 expression levels and CD8 + T cell infiltration, Scatter plot showing the correlation between NOX4 expression levels and CD8 + T cell infiltration in breast cancer (BRCA) samples (n=1100). Rho=0.346, p=2.57e-26. (B) TISIDB data: Scatter plot showing the correlation between NOX4 expression and central memory CD8 + T cell (Tcm-CD8) infiltration, effector memory CD8+ T cell (Tem-CD8) in BRCA samples (n=1100). Rho=0.44, p<2.2e-16; Rho=0.171, p<1.24e-6. (C) Representative flow cytometry plots showing the percentage of CD8 + T cells within the CD45 + population in EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of CD8 + cells, showing a significant reduction in CD8 + T cell infiltration in NOX4 KO tumors ***p<0.001. n=6 per group. (D) Representative flow cytometry plots showing IFN-γ and Granzyme B expression in CD8 + T cells from EO771 tumors of NOX4 WT and NOX4 KO mice. Bar graphs quantifying the percentage of CD8 + T cells expressing IFN-γ and Granzyme B, ***p<0.001. n=7 per group. (E) Representative flow cytometry plots showing the percentage of DC cells within the EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of DC cells, **p<0.01. n=7 per group. (F) TISIDB data: Scatter plot showing the correlation between NOX4 expression and <t>CCL11</t> expression in BRCA samples (n=1100). A significant positive correlation is observed. Rho=0.359, p<2.2e-16. Bar graph showing the concentration of CCL11, CCL5 in the tumor microenvironment, *p<0.05. Data are presented as mean ± SEM from 3 independent experiments. Statistical significance was determined using two-tailed Student’s t-test.
    Recombinant Human Ccl5 Protein, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human ccl5 protein/product/Abnova
    Average 90 stars, based on 1 article reviews
    recombinant human ccl5 protein - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human ccl5 rantes protein
    A MAP chip for quantitative analysis of immune cell migration characteristics at a single-cell level (A) The MAP chip contains four different sets of microchannels: chemotaxis, chemotactic maze, dual taxis, and distance dual taxis. Monocytes are loaded into the CENTRAL chamber of a primed MAP chip and can migrate through the microchannels into the CHEMOKINE chambers. (B) An experimental pipeline illustrating how human monocytes from different donor groups were isolated, stimulated if applicable, and loaded into the MAP chip primed with either CCL2 or <t>CCL5</t> chemokine. Cell motility was then tracked at a single-cell resolution using time-lapse imaging. The data were quantified to detail monocyte migration characteristics. Additionally, flow cytometry was performed on the monocytes to quantify specific receptor expression levels.
    Recombinant Human Ccl5 Rantes Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human ccl5 rantes protein/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant human ccl5 rantes protein - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems rn 010 dextran
    A MAP chip for quantitative analysis of immune cell migration characteristics at a single-cell level (A) The MAP chip contains four different sets of microchannels: chemotaxis, chemotactic maze, dual taxis, and distance dual taxis. Monocytes are loaded into the CENTRAL chamber of a primed MAP chip and can migrate through the microchannels into the CHEMOKINE chambers. (B) An experimental pipeline illustrating how human monocytes from different donor groups were isolated, stimulated if applicable, and loaded into the MAP chip primed with either CCL2 or <t>CCL5</t> chemokine. Cell motility was then tracked at a single-cell resolution using time-lapse imaging. The data were quantified to detail monocyte migration characteristics. Additionally, flow cytometry was performed on the monocytes to quantify specific receptor expression levels.
    Rn 010 Dextran, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rn 010 dextran/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    rn 010 dextran - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human ccl5 rantes protein r d systems cat
    A MAP chip for quantitative analysis of immune cell migration characteristics at a single-cell level (A) The MAP chip contains four different sets of microchannels: chemotaxis, chemotactic maze, dual taxis, and distance dual taxis. Monocytes are loaded into the CENTRAL chamber of a primed MAP chip and can migrate through the microchannels into the CHEMOKINE chambers. (B) An experimental pipeline illustrating how human monocytes from different donor groups were isolated, stimulated if applicable, and loaded into the MAP chip primed with either CCL2 or <t>CCL5</t> chemokine. Cell motility was then tracked at a single-cell resolution using time-lapse imaging. The data were quantified to detail monocyte migration characteristics. Additionally, flow cytometry was performed on the monocytes to quantify specific receptor expression levels.
    Human Ccl5 Rantes Protein R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ccl5 rantes protein r d systems cat/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human ccl5 rantes protein r d systems cat - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    Serum CCR1 ligand concentrations (pg/mg) at baseline (t = 0 min) and at the end of the experiment (t = 210 min). Light grey bars: vehicle treatment, n = 7. Dark grey bars: 0.5 μmol/kg BX471 treatment, n = 7. ( A ) CCL3, ( B ) CCL4, ( C ) CCL5, and ( D ) CCL7. *: p < 0.05 vs. baseline (t = 0 min).

    Journal: Biomedicines

    Article Title: The Chemokine (C-C Motif) Receptor 1 Antagonist BX471 Improves Fluid Resuscitation in Rat Models of Hemorrhagic Shock

    doi: 10.3390/biomedicines13051241

    Figure Lengend Snippet: Serum CCR1 ligand concentrations (pg/mg) at baseline (t = 0 min) and at the end of the experiment (t = 210 min). Light grey bars: vehicle treatment, n = 7. Dark grey bars: 0.5 μmol/kg BX471 treatment, n = 7. ( A ) CCL3, ( B ) CCL4, ( C ) CCL5, and ( D ) CCL7. *: p < 0.05 vs. baseline (t = 0 min).

    Article Snippet: Measurements of Chemokine Concentrations: Serum levels of CCL3, CCL4, CCL5, and CCL7 were measured with commercially available rat enzyme-linked immunosorbent assays (ELISA, Boster Bio, Pleasanton, CA, USA) according to the manufacturer’s instructions.

    Techniques:

    NOX4 enhanced the CD8 + T cells mediate antitumor effect. (A) TIMER2.0 was used to analysis the correlation between NOX4 expression levels and CD8 + T cell infiltration, Scatter plot showing the correlation between NOX4 expression levels and CD8 + T cell infiltration in breast cancer (BRCA) samples (n=1100). Rho=0.346, p=2.57e-26. (B) TISIDB data: Scatter plot showing the correlation between NOX4 expression and central memory CD8 + T cell (Tcm-CD8) infiltration, effector memory CD8+ T cell (Tem-CD8) in BRCA samples (n=1100). Rho=0.44, p<2.2e-16; Rho=0.171, p<1.24e-6. (C) Representative flow cytometry plots showing the percentage of CD8 + T cells within the CD45 + population in EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of CD8 + cells, showing a significant reduction in CD8 + T cell infiltration in NOX4 KO tumors ***p<0.001. n=6 per group. (D) Representative flow cytometry plots showing IFN-γ and Granzyme B expression in CD8 + T cells from EO771 tumors of NOX4 WT and NOX4 KO mice. Bar graphs quantifying the percentage of CD8 + T cells expressing IFN-γ and Granzyme B, ***p<0.001. n=7 per group. (E) Representative flow cytometry plots showing the percentage of DC cells within the EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of DC cells, **p<0.01. n=7 per group. (F) TISIDB data: Scatter plot showing the correlation between NOX4 expression and CCL11 expression in BRCA samples (n=1100). A significant positive correlation is observed. Rho=0.359, p<2.2e-16. Bar graph showing the concentration of CCL11, CCL5 in the tumor microenvironment, *p<0.05. Data are presented as mean ± SEM from 3 independent experiments. Statistical significance was determined using two-tailed Student’s t-test.

    Journal: Frontiers in Immunology

    Article Title: NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8 + T cell antitumor activity

    doi: 10.3389/fimmu.2025.1534936

    Figure Lengend Snippet: NOX4 enhanced the CD8 + T cells mediate antitumor effect. (A) TIMER2.0 was used to analysis the correlation between NOX4 expression levels and CD8 + T cell infiltration, Scatter plot showing the correlation between NOX4 expression levels and CD8 + T cell infiltration in breast cancer (BRCA) samples (n=1100). Rho=0.346, p=2.57e-26. (B) TISIDB data: Scatter plot showing the correlation between NOX4 expression and central memory CD8 + T cell (Tcm-CD8) infiltration, effector memory CD8+ T cell (Tem-CD8) in BRCA samples (n=1100). Rho=0.44, p<2.2e-16; Rho=0.171, p<1.24e-6. (C) Representative flow cytometry plots showing the percentage of CD8 + T cells within the CD45 + population in EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of CD8 + cells, showing a significant reduction in CD8 + T cell infiltration in NOX4 KO tumors ***p<0.001. n=6 per group. (D) Representative flow cytometry plots showing IFN-γ and Granzyme B expression in CD8 + T cells from EO771 tumors of NOX4 WT and NOX4 KO mice. Bar graphs quantifying the percentage of CD8 + T cells expressing IFN-γ and Granzyme B, ***p<0.001. n=7 per group. (E) Representative flow cytometry plots showing the percentage of DC cells within the EO771 tumors from NOX4 wild-type (WT) and NOX4 knockout (KO) mice. Bar graph quantifying the percentage of DC cells, **p<0.01. n=7 per group. (F) TISIDB data: Scatter plot showing the correlation between NOX4 expression and CCL11 expression in BRCA samples (n=1100). A significant positive correlation is observed. Rho=0.359, p<2.2e-16. Bar graph showing the concentration of CCL11, CCL5 in the tumor microenvironment, *p<0.05. Data are presented as mean ± SEM from 3 independent experiments. Statistical significance was determined using two-tailed Student’s t-test.

    Article Snippet: The quantity of CCL11, CCL5 (Bosterbio) were determined in tumor tissue using ELISA kits according to the manufacturer’s instructions.

    Techniques: Expressing, Flow Cytometry, Knock-Out, Concentration Assay, Two Tailed Test

    A MAP chip for quantitative analysis of immune cell migration characteristics at a single-cell level (A) The MAP chip contains four different sets of microchannels: chemotaxis, chemotactic maze, dual taxis, and distance dual taxis. Monocytes are loaded into the CENTRAL chamber of a primed MAP chip and can migrate through the microchannels into the CHEMOKINE chambers. (B) An experimental pipeline illustrating how human monocytes from different donor groups were isolated, stimulated if applicable, and loaded into the MAP chip primed with either CCL2 or CCL5 chemokine. Cell motility was then tracked at a single-cell resolution using time-lapse imaging. The data were quantified to detail monocyte migration characteristics. Additionally, flow cytometry was performed on the monocytes to quantify specific receptor expression levels.

    Journal: Cell Reports Methods

    Article Title: Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues

    doi: 10.1016/j.crmeth.2024.100846

    Figure Lengend Snippet: A MAP chip for quantitative analysis of immune cell migration characteristics at a single-cell level (A) The MAP chip contains four different sets of microchannels: chemotaxis, chemotactic maze, dual taxis, and distance dual taxis. Monocytes are loaded into the CENTRAL chamber of a primed MAP chip and can migrate through the microchannels into the CHEMOKINE chambers. (B) An experimental pipeline illustrating how human monocytes from different donor groups were isolated, stimulated if applicable, and loaded into the MAP chip primed with either CCL2 or CCL5 chemokine. Cell motility was then tracked at a single-cell resolution using time-lapse imaging. The data were quantified to detail monocyte migration characteristics. Additionally, flow cytometry was performed on the monocytes to quantify specific receptor expression levels.

    Article Snippet: Recombinant Human CCL5/RANTES Protein , R&D Systems , Cat. #278-RN-010.

    Techniques: Migration, Chemotaxis Assay, Isolation, Imaging, Flow Cytometry, Expressing

    Monocytes migrate through the path of lower hydraulic resistance regardless of donor age or proinflammatory cytokine stimulation (A) The dual-taxis microchannels contain a chemotactic gradient and varying hydraulic resistances. At the bifurcation of each microchannel, the hydraulic resistance is increased by 6×, 14×, or 51× in the right path compared to the left path. (B) Schematic showing a magnified view of the bifurcation within the 6× hydraulic resistance design. (C) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the dual-taxis microchannels primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (D) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (E–I) The migration ratio of monocytes in response to 100 nM CCL2 chemokine and varying hydraulic resistances ( n = 17–18 healthy unstimulated, n = 3–5 19- to 27-year-old, n = 6 50- to 60-year-old, n = 7 GM-CSF-stimulated donors, and n = 7–8 IFN-γ-stimulated donors). (J–L) The migration ratio of monocytes in response to 100 nM CCL5 chemokine and varying hydraulic resistances ( n = 6–8 healthy unstimulated, n = 7 GM-CSF-stimulated, and n = 7–8 IFN-γ-stimulated donors). p values are from Welch’s t test (D) and one-sample t and Wilcoxon tests (E–L). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Journal: Cell Reports Methods

    Article Title: Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues

    doi: 10.1016/j.crmeth.2024.100846

    Figure Lengend Snippet: Monocytes migrate through the path of lower hydraulic resistance regardless of donor age or proinflammatory cytokine stimulation (A) The dual-taxis microchannels contain a chemotactic gradient and varying hydraulic resistances. At the bifurcation of each microchannel, the hydraulic resistance is increased by 6×, 14×, or 51× in the right path compared to the left path. (B) Schematic showing a magnified view of the bifurcation within the 6× hydraulic resistance design. (C) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the dual-taxis microchannels primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (D) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (E–I) The migration ratio of monocytes in response to 100 nM CCL2 chemokine and varying hydraulic resistances ( n = 17–18 healthy unstimulated, n = 3–5 19- to 27-year-old, n = 6 50- to 60-year-old, n = 7 GM-CSF-stimulated donors, and n = 7–8 IFN-γ-stimulated donors). (J–L) The migration ratio of monocytes in response to 100 nM CCL5 chemokine and varying hydraulic resistances ( n = 6–8 healthy unstimulated, n = 7 GM-CSF-stimulated, and n = 7–8 IFN-γ-stimulated donors). p values are from Welch’s t test (D) and one-sample t and Wilcoxon tests (E–L). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Article Snippet: Recombinant Human CCL5/RANTES Protein , R&D Systems , Cat. #278-RN-010.

    Techniques: Confocal Microscopy, Imaging, Membrane, Migration

    Spatial confinement does not dictate the migration of human monocytes toward lower hydraulic resistance paths (A) The distance dual-taxis microchannels contain equal dimensions at the bifurcation and varying distances to a change in width and, consequentially, hydraulic pressure. The left channel has lower hydraulic resistance, and the right path has a 9.2×, 7.6×, 5.3×, or 3.5× greater hydraulic resistances. (B) Schematic showing a monocyte experiencing equal spatial confinement at the bifurcation but different hydraulic resistances. (C) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the distance dual-taxis microchannels primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (D) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (E–G) The migration ratio of monocytes in response to CCL2 and varying hydraulic resistances ( n = 17–18 healthy unstimulated, n = 4–5 19- to 27-year-old, and n = 6 50- to 60-year-old donors). (H and I) Quantification of the migration velocity of monocytes from 19- to 27-year-old ( n = 5) and 50- to 60-year-old donors ( n = 5) in response to 100 nM CCL2 chemokine. (J and K) The migration ratio of stimulated monocytes in response to CCL2 and varying hydraulic resistances ( n = 8 GM-CSF-stimulated and n = 7–8 IFN-γ-stimulated donors). (L–N) The migration ratio of stimulated monocytes in response to CCL5 and varying hydraulic resistances ( n = 8 healthy unstimulated, n = 7–8 GM-CSF-stimulated, and n = 8 IFN-γ-stimulated donors). (O and P) Quantification of monocyte migration velocity toward (O) 100 nM CCL2 or (P) CCL5 chemokine when unstimulated ( n = 16 donors for CCL2 and n = 6 donors for CCL5), GM-CSF stimulated ( n = 6 donors for CCL2 and CCL5), or IFN-γ stimulated ( n = 4 donors for CCL2 and n = 6 for CCL5). p values are from Mann-Whitney test (D and I), one sample t and Wilcoxon tests (E–G and J–N), Welch’s t test (H), and two-way ANOVA (O and P). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Journal: Cell Reports Methods

    Article Title: Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues

    doi: 10.1016/j.crmeth.2024.100846

    Figure Lengend Snippet: Spatial confinement does not dictate the migration of human monocytes toward lower hydraulic resistance paths (A) The distance dual-taxis microchannels contain equal dimensions at the bifurcation and varying distances to a change in width and, consequentially, hydraulic pressure. The left channel has lower hydraulic resistance, and the right path has a 9.2×, 7.6×, 5.3×, or 3.5× greater hydraulic resistances. (B) Schematic showing a monocyte experiencing equal spatial confinement at the bifurcation but different hydraulic resistances. (C) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the distance dual-taxis microchannels primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (D) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (E–G) The migration ratio of monocytes in response to CCL2 and varying hydraulic resistances ( n = 17–18 healthy unstimulated, n = 4–5 19- to 27-year-old, and n = 6 50- to 60-year-old donors). (H and I) Quantification of the migration velocity of monocytes from 19- to 27-year-old ( n = 5) and 50- to 60-year-old donors ( n = 5) in response to 100 nM CCL2 chemokine. (J and K) The migration ratio of stimulated monocytes in response to CCL2 and varying hydraulic resistances ( n = 8 GM-CSF-stimulated and n = 7–8 IFN-γ-stimulated donors). (L–N) The migration ratio of stimulated monocytes in response to CCL5 and varying hydraulic resistances ( n = 8 healthy unstimulated, n = 7–8 GM-CSF-stimulated, and n = 8 IFN-γ-stimulated donors). (O and P) Quantification of monocyte migration velocity toward (O) 100 nM CCL2 or (P) CCL5 chemokine when unstimulated ( n = 16 donors for CCL2 and n = 6 donors for CCL5), GM-CSF stimulated ( n = 6 donors for CCL2 and CCL5), or IFN-γ stimulated ( n = 4 donors for CCL2 and n = 6 for CCL5). p values are from Mann-Whitney test (D and I), one sample t and Wilcoxon tests (E–G and J–N), Welch’s t test (H), and two-way ANOVA (O and P). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Article Snippet: Recombinant Human CCL5/RANTES Protein , R&D Systems , Cat. #278-RN-010.

    Techniques: Migration, Confocal Microscopy, Imaging, Membrane, MANN-WHITNEY

    IFN-γ stimulation, not aging, hinders human monocyte chemotaxis through complex pathways (A) Schematic showing the chemotactic maze with several decision-making forks. (B) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the chemotactic maze primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (C) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (D–G) Quantification of normalized monocyte migration (D), track duration (E), track length (F), and migration velocity (G) in response to 100 nM CCL2 chemokine for 19- to 27-year-old ( n = 3–5) and 50- to 60-year-old ( n = 6) donors. (H–K) Quantification of normalized monocyte migration (H), track duration (I), track length (J), and migration velocity (K) in response to 100 nM CCL2 chemokine for unstimulated ( n = 17–18 donors), GM-CSF-stimulated ( n = 8 donors), and IFN-γ-stimulated ( n = 8 donors) monocytes from deidentified donors. (L–O) Quantification of normalized monocyte migration (L), track duration (M), track length (N), and migration velocity (O) in response to 100 nM CCL5 chemokine for unstimulated ( n = 8 donors), GM-CSF-stimulated ( n = 7–8 donors), and IFN-γ-stimulated ( n = 8 donors) monocytes from deidentified donors. p values are from Mann-Whitney test (C), Welch’s t test (D–G), Brown-Forsythe and Welch ANOVA tests (H and L), Kruskal-Wallis test (I, J, M, and N), and one-way ANOVA (K and O). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Journal: Cell Reports Methods

    Article Title: Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues

    doi: 10.1016/j.crmeth.2024.100846

    Figure Lengend Snippet: IFN-γ stimulation, not aging, hinders human monocyte chemotaxis through complex pathways (A) Schematic showing the chemotactic maze with several decision-making forks. (B) Representative time-lapse confocal microscopy imaging of monocytes (cell membrane, green; nuclei, blue) in the chemotactic maze primed with 100 nM CCL2 chemokine. Scale bar, 10 μm. (C) The number of migrating monocytes in the presence of CCL2 gradient or evenly distributed chemokine ( n = 6 independent MAP chips). (D–G) Quantification of normalized monocyte migration (D), track duration (E), track length (F), and migration velocity (G) in response to 100 nM CCL2 chemokine for 19- to 27-year-old ( n = 3–5) and 50- to 60-year-old ( n = 6) donors. (H–K) Quantification of normalized monocyte migration (H), track duration (I), track length (J), and migration velocity (K) in response to 100 nM CCL2 chemokine for unstimulated ( n = 17–18 donors), GM-CSF-stimulated ( n = 8 donors), and IFN-γ-stimulated ( n = 8 donors) monocytes from deidentified donors. (L–O) Quantification of normalized monocyte migration (L), track duration (M), track length (N), and migration velocity (O) in response to 100 nM CCL5 chemokine for unstimulated ( n = 8 donors), GM-CSF-stimulated ( n = 7–8 donors), and IFN-γ-stimulated ( n = 8 donors) monocytes from deidentified donors. p values are from Mann-Whitney test (C), Welch’s t test (D–G), Brown-Forsythe and Welch ANOVA tests (H and L), Kruskal-Wallis test (I, J, M, and N), and one-way ANOVA (K and O). Boxplots show the median and the range between the 25th and 75th percentiles. The whiskers stretch from the minimum and maximum values.

    Article Snippet: Recombinant Human CCL5/RANTES Protein , R&D Systems , Cat. #278-RN-010.

    Techniques: Chemotaxis Assay, Confocal Microscopy, Imaging, Membrane, Migration, MANN-WHITNEY

    Journal: Cell Reports Methods

    Article Title: Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues

    doi: 10.1016/j.crmeth.2024.100846

    Figure Lengend Snippet:

    Article Snippet: Recombinant Human CCL5/RANTES Protein , R&D Systems , Cat. #278-RN-010.

    Techniques: Blocking Assay, Recombinant, Modification, Saline, Isolation, Selection, Staining, Electron Microscopy, Software